Telomir Pharmaceuticals (TELO) Earnings Date, Estimates & Call Transcripts $1.96 -0.04 (-2.00%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.96 0.00 (-0.20%) As of 06/13/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Telomir Pharmaceuticals Earnings Summary Telomir Pharmaceuticals announced Q1 2025 earnings on May 12, 2025, reporting an EPS of -$0.07, which topped the consensus estimate of -$0.10 by $0.03. With a trailing EPS of -$0.42, Telomir Pharmaceuticals' earnings are expected to grow next year, from ($0.40) to ($0.36) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportTELO Upcoming EarningsTelomir Pharmaceuticals' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Upcoming Q2 Earnings DateAug. 12EstimatedConsensus EPS (May. 12) -$0.10 Actual EPS (May. 12) -$0.07 Beat By $0.03 Get Telomir Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Telomir Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTELO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Telomir Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.10-$0.10-$0.10Q2 20251-$0.10-$0.10-$0.10Q3 20251-$0.10-$0.10-$0.10Q4 20251-$0.10-$0.10-$0.10 FY 2025 4 -$0.40 -$0.40 -$0.40 Q1 20261-$0.09-$0.09-$0.09Q2 20261-$0.10-$0.10-$0.10Q3 20261-$0.08-$0.08-$0.08Q4 20261-$0.09-$0.09-$0.09 Telomir Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/12/2025Q1 2025-$0.10-$0.07+$0.03-$0.07--2/4/2025Q4 2024-$0.05-$0.10 -$0.05-$0.10--11/12/2024---$0.20 -$0.20-$0.20--8/13/2024Q2 2024--$0.05 -$0.05-$0.05--5/13/2024Q1 2024--$0.23 -$0.23-$0.23-- Telomir Pharmaceuticals Earnings - Frequently Asked Questions When is Telomir Pharmaceuticals' earnings date? Telomir Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on TELO's earnings history. Did Telomir Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Telomir Pharmaceuticals (NASDAQ:TELO) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.10) by $0.03. Learn more on analysts' earnings estimate vs. TELO's actual earnings. How much profit does Telomir Pharmaceuticals generate each year? Telomir Pharmaceuticals (NASDAQ:TELO) has a recorded net income of -$16.53 million. TELO has generated -$0.42 earnings per share over the last four quarters. What is Telomir Pharmaceuticals' EPS forecast for next year? Telomir Pharmaceuticals' earnings are expected to grow from ($0.40) per share to ($0.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies ESPR Earnings Results YMAB Earnings Results MDWD Earnings Results SLRN Earnings Results DSGN Earnings Results BTMD Earnings Results SCPH Earnings Results AVTE Earnings Results KOD Earnings Results INBX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:TELO) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
